Comprehensive Index of National Vaccine Injury Compensation Program Cases ← all cases Home Firms Attorneys Stats Special Masters About Us
Looking for representation? Submit a free inquiry →

Mark L. Krueger — Petitioner Attorney, U.S. Vaccine Court

Petitioner attorney U.S. Court of Federal Claims · Office of Special Masters Last verified
Cases filed
34
Comp rate
53%
Total awarded
$3.9M
Years active
2014–2023
FirmsKrueger & Hernandez, S.C. (32) · Mark L. Krueger (1)
Heads up: The case docket, statistics, and overview below are compiled from AI-extracted data. Specific figures (case counts, awards, outcomes) may contain errors. Verify with the attorney directly or with source court records before relying on them.

About Mark L. Krueger

Mark Krueger is co-founder of Krueger Hernandez & Thompson SC (formerly Krueger & Hernandez SC) in Wisconsin, with offices in Middleton and Baraboo, and more than 27 years of experience representing vaccine recipients who suffered adverse reactions. He is one of a small number of U.S. attorneys focused on vaccine injury practice before the U.S. Court of Federal Claims and has represented petitioners nationwide.

AI-generated overview · may contain errors. Verify details with the attorney directly before relying on them.
Sources: [1]

VICP practice summary

Mark L. Krueger is a petitioner attorney with the U.S. Court of Federal Claims, Office of Special Masters, who has filed 34 petitions in the National Vaccine Injury Compensation Program (VICP) between 2014 and 2023. The practice focuses on Other / multiple (15 cases, 27% comp rate), Guillain-Barré Syndrome (GBS) (8 cases, 100% comp rate), and Transverse myelitis (6 cases, 33% comp rate), among other vaccine-related injuries. Cases filed by Mark L. Krueger have resulted in $3.9M in total compensation awards (53% compensation rate across all petitions). Practice has been associated with Krueger & Hernandez, S.C., as well as Mark L. Krueger.

Practice pattern

Comp rate by condition

Other / multiple-21pt
15 cases · 4 compensated
This attorney
27%
Program
48%
Guillain-Barré Syndrome (GBS)+16pt
8 cases · 8 compensated
This attorney
100%
Program
84%
Transverse myelitis-42pt
6 cases · 2 compensated
This attorney
33%
Program
75%

Comp rate by vaccine

Influenza-6pt
14 cases · 11 compensated
This attorney
79%
Program
85%
HPV-25pt
10 cases · 1 compensated
This attorney
10%
Program
35%

Frequently asked questions about Mark L. Krueger

Answers built from this attorney's public case docket.

How do I find a good VICP lawyer?
Most petitioners hire counsel because the program's evidentiary burden, expert-witness requirements, and procedural rules are complex. Reasonable attorney fees in VICP cases are paid by the program — not by the petitioner — under 42 U.S.C. § 300aa-15(e)(1), so engaging counsel does not reduce a successful petitioner's recovery. You can submit a free inquiry → to have your case forwarded to attorneys with VICP experience, or browse this index to research individual attorneys' case histories.
Who is Mark L. Krueger?
Mark L. Krueger is a petitioner attorney with the U.S. Court of Federal Claims, Office of Special Masters, who represents petitioners in the National Vaccine Injury Compensation Program (VICP). The VICP Registry shows 34 petitions filed by Mark L. Krueger between 2014 and 2023.
How many VICP cases has Mark L. Krueger filed?
Mark L. Krueger has filed 34 petitions in the National Vaccine Injury Compensation Program according to the VICP Registry. Of these, 18 resulted in compensation, for an overall compensation rate of 53%.
What is Mark L. Krueger's VICP compensation rate?
Mark L. Krueger's overall compensation rate across all VICP petitions is 53% (18 compensated cases out of 34 total).
What is the total amount awarded in cases filed by Mark L. Krueger?
Cases filed by Mark L. Krueger have resulted in $3.9M in total compensation awards from the U.S. Vaccine Injury Compensation Program. This figure reflects only awards visible in published Court of Federal Claims decisions; settlements with non-public terms are not included.
What types of vaccine injury cases does Mark L. Krueger typically handle?
Based on case data in the VICP Registry, Mark L. Krueger's practice includes Other / multiple, Guillain-Barré Syndrome (GBS), Transverse myelitis, among other vaccine-related conditions. The full case history is available on this page.
What law firm is Mark L. Krueger associated with?
Mark L. Krueger has been associated with Krueger & Hernandez, S.C., Mark L. Krueger in cases filed under the National Vaccine Injury Compensation Program.
FiledDecidedPetitionerAttorneyFirm Age at VaccinationVaccineCondition OutcomeSpecial MasterAward
2013-05-222023-09-12Cristal BelloMark L. Krueger, Mark T. SadakaKrueger & Hernandez, S.C.; Law Offices of Sadaka Associates, LLC23.0yHPVpremature ovarian failuredeniedLisa D. Hamilton-Fieldman–
2014-09-182022-11-28Whitney AlexanderMark L. Krueger, Mark T. SadakaKrueger & Hernandez, S.C.; Law Offices of Sadaka Associates, LLC–HPVpremature ovarian failure/primary ovarian insufficiencydismissedLisa D. Hamilton-Fieldman–
2016-09-282018-04-05Rebecca SchleifMark L. Krueger, Andrew Mark KruegerKrueger & Hernandez, S.C.–Tdapleft shoulder injurycompensatedNora Beth Dorsey$182,500
2014-01-152017-10-10Anthony RagusaMark L. KruegerKrueger & Hernandez, S.C.–influenzatransverse myelitisdismissedChristian J. Moran–
2015-09-162017-06-15Z.J.C.deathMark L. KruegerKrueger & Hernandez, S.C.1.2yDTaPanoxia due to, or as a consequence of, acute bronchopneumonidismissedChristian J. Moran–
2017-03-302017-05-03Lillian RiveraMark L. KruegerKrueger & Hernandez, SC–influenzaTransverse MyelitiscompensatedBrian H. Corcoran$241,250
2015-06-232017-04-24Janette H. HerreraMark L. KruegerKrueger & Hernandez S.C.–HPVmultiple sclerosiscompensatedThomas L. Gowen$255,000
2012-10-262017-04-21Kevin Mancilla LopezMark L. KruegerKrueger & Hernandez–TDaPGuillain-Barre Syndrome (GBS) and/or Acute Disseminated EncecompensatedMindy Michaels Roth$1,230,510
2016-02-172016-11-04Melissa WagnerMark L. KruegerKrueger & Hernandez, S.C.–influenzaleft shoulder synovitis and adhesive capsulitiscompensatedNora Beth Dorsey$122,500
2015-01-292016-07-13J.D.B.Mark L. KruegerKrueger & Hernandez, S.C.–DTaPidiopathic thrombocytopenic purpura (ITP)compensatedMindy Michaels Roth$110,000
2010-11-082016-06-06Madelyne MeylorMark L. KruegerKrueger & Hernandez, S.C.; Krueger & Hernandez, SC14.6yHPVpremature ovarian failure (POI)dismissedLisa D. Hamilton-Fieldman$2,329
2010-11-082016-06-06Olivia MeylorMark L. KruegerKrueger & Hernandez, S.C.; Krueger & Hernandez, SC13.1yHPVPremature Ovarian Failure (POF) / Primary Ovarian InsufficiedismissedLisa D. Hamilton-Fieldman$122,229
2013-04-252016-06-02Jessica L. LaughlinMark KruegerKrueger & Hernandez, SC21.0yGardasilPremature Ovarian Failure (POF); Primary Ovarian InsufficiendismissedLisa D. Hamilton-Fieldman–
2014-02-272016-06-02Meghan McSherryMark KruegerKrueger & Hernandez, SC20.1yHPVPremature Ovarian Failure (POF) / Primary Ovarian InsufficiedismissedLisa D. Hamilton-Fieldman–
2014-02-272016-06-02Lydia McSherryMark KruegerKrueger & Hernandez, SC16.9yHPVprimary ovarian insufficiency (POI)dismissedLisa D. Hamilton-Fieldman–
2014-04-022016-06-02Lauren Natalie LeeMark KruegerKrueger & Hernandez, SC24.0yHPVPrimary Ovarian Insufficiency (POI)dismissedLisa D. Hamilton-Fieldman–
2014-04-182016-06-02Emily CulliganMark KruegerKrueger & Hernandez, SC25.8yHPVPrimary Ovarian Insufficiency (POI)dismissedLisa D. Hamilton-Fieldman–
2015-11-242016-06-02Rebecca FishkisMark L. KruegerKrueger & Hernandez, S.C.; Krueger & Hernandez, SC13.0yHPVPremature ovarian failure (POF) / Primary Ovarian InsufficiedismissedLisa D. Hamilton-Fieldman$2,049
2015-02-112016-06-02Katelyn GarnerMark KruegerKrueger & Hernandez, SC12.7yGardasilprimary ovarian insufficiency (POI)dismissedLisa D. Hamilton-Fieldman–
2016-04-132016-05-04F.M.K.deathMark L. KruegerKrueger & Hernandez, S.C.–MMRseizures, decrease in function, and regression in her GMI gacompensatedChristian J. Moran$56,099
2015-03-042016-03-24N.Y.Mark L. KruegerKrueger & Hernandez, S.C.–Haemophilus influenzae type btransverse myelitisdismissedChristian J. Moran$11,497
2016-02-122016-03-18Roberta ReynaMark L. KruegerKrueger & Hernandez–influenzatransverse myelitiscompensatedThomas L. Gowen$198,144
2013-07-182015-12-11W.T.M.Mark L. KruegerKrueger & Hernandez, S.C.–MMRcerebrovascular incidentcompensatedThomas L. Gowen$460,135
2013-10-282015-10-30Kevin M. MeaneyMark L. KruegerKrueger & Hernandez, S.C.–influenzaGuillain-Barre syndrome (GBS)compensatedNora Beth Dorsey$75,591
2015-08-112015-09-01Albert J. MichaelsMark L. KruegerKrueger & Hernandez, S.C.–influenzaserum sickness type autoimmune reactioncompensatedLisa D. Hamilton-Fieldman$18,500
2014-10-162015-08-26Shari BuetowMark L. KruegerMark L. Krueger–influenzatransverse myelitisdismissedThomas L. Gowen–
2014-10-232015-06-18Heather CookMark L. KruegerKrueger & Hernandez, S.C.44.0yinfluenzashoulder injury related to vaccine administration ("SIRVA")compensatedDenise K. Vowell$70,000
2015-04-232015-05-14Nona JonesMark L. KruegerKrueger & Hernandez, S.C.–influenzaGuillain-Barré syndrome (GBS)compensatedDenise K. Vowell$151,849
2015-02-092015-03-03H.D.M.Mark L. KruegerKrueger & Hernandez, S.C.–influenzatransverse myelitisdismissedNora Beth Dorsey$12,291
2015-01-132015-02-06Cathy ErdmannMark L. KruegerKrueger & Hernandez, S.C.–influenzaGuillain-Barré syndromecompensatedBrian H. Corcoran$302,036
2014-12-012014-12-23Howard S. KahnMark L. KruegerKrueger & Hernandez, S.C.–influenzachronic inflammatory demyelinating polyneuropathy (CIDP) andcompensatedLisa D. Hamilton-Fieldman$130,000
2013-12-112014-11-24Angel DavisMark L. KruegerKrueger & Hernandez, S.C.–influenzaGuillain-Barré syndrome (GBS)compensatedNora Beth Dorsey$81,167
2014-01-092014-10-24Richard SewellMark L. KruegerKrueger & Hernandez S.C.–influenzaGuillain-Barre Syndrome and Brachial NeuritiscompensatedThomas L. Gowen$65,173
2014-05-132014-05-13Matthew Forrest KierzekMark L. Krueger––TdapGuillain-Barré SyndromecompensatedLaura D. Millman$128,324